Late onset preeclampsia is not an innocuous condition
dc.contributor.author | Kenneth L. | |
dc.contributor.author | Hall D.R. | |
dc.contributor.author | Gebhardt S. | |
dc.contributor.author | Grove D. | |
dc.date.accessioned | 2011-05-15T16:16:36Z | |
dc.date.available | 2011-05-15T16:16:36Z | |
dc.date.issued | 2010 | |
dc.description.abstract | Objective: To describe the profile and outcome of late-onset preeclampsia (LOPE). Methods. Retrospective study of 264 singleton pregnancies presenting before delivery at two referral centres in South Africa. Results: Primigravid patients constituted 56.8% of the group, while 57.6% were graded as severe. Median gestational age at diagnosis was 37 (34-43) weeks. 30.7% of patients experienced ≥1 major maternal complication including 34 (12.9%) cases of eclampsia. There were no maternal or early neonatal deaths. Five intrauterine deaths occurred, all due to placental abruption. The perinatal mortality rate was 18.9 per thousand births. Conclusions: Late-onset preeclampsia often presents as severe disease. © 2010 Informa UK, Ltd. | |
dc.description.version | Article | |
dc.identifier.citation | Hypertension in Pregnancy | |
dc.identifier.citation | 29 | |
dc.identifier.citation | 3 | |
dc.identifier.issn | 10641955 | |
dc.identifier.other | 10.3109/10641950902777697 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13855 | |
dc.subject | atenolol | |
dc.subject | dihydralazine | |
dc.subject | enalapril | |
dc.subject | labetalol | |
dc.subject | magnesium sulfate | |
dc.subject | methyldopa | |
dc.subject | nifedipine | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | birth | |
dc.subject | death | |
dc.subject | disease severity | |
dc.subject | eclampsia | |
dc.subject | female | |
dc.subject | fetus death | |
dc.subject | gestational age | |
dc.subject | HELLP syndrome | |
dc.subject | human | |
dc.subject | hypertension | |
dc.subject | intensive care | |
dc.subject | kidney disease | |
dc.subject | lung edema | |
dc.subject | major clinical study | |
dc.subject | medical record review | |
dc.subject | newborn death | |
dc.subject | patient referral | |
dc.subject | perinatal mortality | |
dc.subject | preeclampsia | |
dc.subject | primigravida | |
dc.subject | retrospective study | |
dc.subject | single drug dose | |
dc.subject | solutio placentae | |
dc.subject | South Africa | |
dc.subject | thrombocytopenia | |
dc.subject | Adult | |
dc.subject | Female | |
dc.subject | Gestational Age | |
dc.subject | Humans | |
dc.subject | Pre-Eclampsia | |
dc.subject | Pregnancy | |
dc.subject | Pregnancy Outcome | |
dc.subject | Prognosis | |
dc.subject | Retrospective Studies | |
dc.subject | Severity of Illness Index | |
dc.subject | South Africa | |
dc.subject | Time Factors | |
dc.title | Late onset preeclampsia is not an innocuous condition | |
dc.type | Article |